Cover Image
市場調查報告書

混合手術室的全球市場 2015-2021年:企業簡介、市場佔有率、市場趨勢、市場規模、市場機會分析、預測

Global Hybrid Operating Rooms Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 344789
出版日期 內容資訊 英文 212 Pages
商品交期: 請詢問到貨日
價格
Back to Top
混合手術室的全球市場 2015-2021年:企業簡介、市場佔有率、市場趨勢、市場規模、市場機會分析、預測 Global Hybrid Operating Rooms Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日期: 2016年02月28日 內容資訊: 英文 212 Pages
簡介

全球混合手術室的市場預計從2015年到2020年以16.66%的年複合成長率成長。最小侵襲手術的需求擴大和醫療部門的各種技術的進步等成為該市場的主要推進因素。

本報告提供全球混合手術室的市場相關調查、市場定義與概要、價值鏈、對市場成長的各種影響因素及市場機會分析、各用途、設備區分、地區/主要國家趨勢及市場規模的變化與預測、競爭環境,以及主要企業的簡介等彙整。

第1章 摘要整理

第2章 市場概要

  • 定義
  • 主要調查結果
  • 主要的購買標準
  • 價值鏈分析

第3章 市場決策因素

  • 引進推進因素
  • 市場障礙
  • 市場機會

第4章 市場分析:各用途

  • 治療
    • 心血管系統手術室
    • 神經外科
    • 胸部外科
    • 切片檢查
    • 整形外科
    • 腹腔鏡外科手術
    • 急救醫療
    • 其他
  • 診斷影像
    • X光掃描透視
    • DSA (數位輔助推動力血管造影術攝影)
    • C臂3D CT

第5章 市場分析:各設備

  • 手術台
    • 移動型手術台
    • 固定型手術台
  • 手術室照明
    • 調光式照明
    • LED照明
    • 鹵素燈
  • 手術用吊桿
  • 外科用影像顯示器
  • 手術中診斷設備
    • 3D超音波
    • MRI
      • 領導品牌、製造商
    • CT
    • 電腦支援機器人手術
    • C臂X光掃描
    • 紅外線成像系統
  • 手術室用通信系統
    • 視聽
    • 手術室整合系統
      • WiFi
      • RFID
      • PACS

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 西班牙
    • 義大利
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 韓國
  • 其他地區
    • 南美
      • 巴西

第7章 競爭環境

  • 主要策略
    • 聯盟
    • 收購
    • 產品推出

第8章 企業簡介

  • Barco Nv
  • Cook Medical
  • Eschmann Equipment
  • GE Healthcare
  • Johnson & Johnson
  • Karl Storz Gmbh & Co. KG
  • Maquet Getinge Group
  • Mediflex
  • Mizuho OSI
  • NDS Surgical Imaging, LLC
  • Philips Healthcare
  • Siemens Healthcare GMBH
  • Sisco Ltd
  • Sklar
  • Skytron, LLC
  • Sontec Instruments
  • Steris Corporation
  • Stryker Corporation
  • 東芝MedicalSystems
  • Trumpf Gmbh + Co. KG
    • 概要
    • 產品系列
    • 策略性趨勢
    • SCOT分析

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HAD-890415

The healthcare industry is gradually transforming from conventional operating methods to intraoperative approach for surgeries. An estimated 234 million major surgeries are performed every year globally which include cardiac catheterizations, endoscopy, neurosurgery and so on. The increasing demand for minimally invasive surgeries is driving growth of hybrid operating rooms. The growing demand for minimally invasive surgeries and various technological innovations in the healthcare industry are the major driving force for the global healthcare industry. However, high cost of establishment and safety concerns are still major challenges before the market. The market is dominated by applications in cardiovascular and neurosurgery both contributing to more than 60% of the market share.

Key companies profiled include

  • 1. Maquet Getinge Group
  • 2. Cook Medical
  • 3. GE Healthcare
  • 4. Karl Storz GmbH & Co. KG
  • 5. Eschmann Equipment
  • 6. Mizuho OSI
  • 7. TRUMPF GmbH + Co. KG
  • 8. Stryker Corporation
  • 9. Skytron, LLC
  • 10. NDS Surgical Imaging, LLC
  • 11. STERIS Corporation
  • 12. Philips Healthcare
  • 13. Siemens Healthcare
  • 14. Toshiba Healthcare
  • 15. Barco
  • 16. Johnson and Johnson
  • 17. SISCO Ltd
  • 18. Sontec Instruments
  • 19. Mediflex
  • 20. Sklar
  • This Occams Research Report covers
  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR upto 2022
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data
  • 6. Deep profiles top competitive companies

Table of Contents

Chap 1. Executive Summary

  • 1.1. Methodology

Chap 2. Market Overview

  • 2.1. Definition
  • 2.2. Key Findings
    • 2.2.1. Market Opportunities are in Asia Pacific
    • 2.2.2. Cardiovascular & Neurosurgery Dominates the Therapeutic Application Market
    • 2.2.3. Demand For Non Invasive Surgeries Is Driving The Market Growth
    • 2.2.4. Surgical Imaging Display Market Promising Great Future
    • 2.2.5. Imaging Systems Will Have The Highest Market Share Driven By Presence Of Major Diagnostic Imaging Companies
    • 2.2.6. Partnerships And Collaborations Are The Winning Strategies For The Market Players
  • 2.3. Key Buying Criteria
    • 2.3.1. Patient Care & Safety
    • 2.3.2. Price
    • 2.3.3. Success Rates
    • 2.3.4. Operating Room Design
  • 2.4. Value Chain Analysis
  • 2.5. Planning And Establishment Of Hybrid Operating Room
    • 2.5.1. Planning
    • 2.5.2. Design And Construction
    • 2.5.3. Location
    • 2.5.4. Imaging Devices
      • 2.5.4.1. Mobile & Fixed Systems
      • 2.5.4.2. Image Intensifier And Flat Panel Detector System
      • 2.5.4.3. Ceiling And Floor Mounted Systems

Chap 3. Market Determinants

  • 3.1. Drivers Of Hybrid Operating Rooms
    • 3.1.1. Healthcare Reforms Advancements In Healthcare Technologies Drive Product Innovation
    • 3.1.2. Benefits Over Conventional Operating Systems Drive Adoption
      • 3.1.2.1. Hybrid Or Provides Maximum Flexibility
      • 3.1.2.2. Clinical Decision Support Systems
    • 3.1.3. Increasing Number Of Ascs (Ambulatory Surgical Centers)
    • 3.1.4. Decreasing Mortality And Morbidity Demands For A Safer Operating Environment
    • 3.1.5. Growing Number Of Heart Patients Globally
    • 3.1.6. Hybrid Approach To Minimally Invasive Heart Surgery
    • 3.1.7. Smart Healthcare Will Drive Faster Adoption
    • 3.1.8. Global Increase In Healthcare Spending
    • 3.1.9. Increasing Number Of Surgeries
  • 3.2. Restraints Of Global Hybrid Operating Rooms Market
    • 3.2.1. High Cost Of Operating Room Equipment
  • 3.3. Market Opportunities
    • 3.3.1. Emerging Economies In Asia-Pacific And Latin America
    • 3.3.2. Technology Is The Key To Success
      • 3.3.2.1. Surgical Therapeutics
      • 3.3.2.2. Robotics

Chap 4. Market Segmentation By Applications

  • 4.1. Therapeutic
    • 4.1.1. Cardiovascular OR
      • 4.1.1.1. Globally CVD Burdens Almost All The Region
      • 4.1.1.2. Research And Development In CVD Therapeutics
    • 4.1.2. Neurosurgery
      • 4.1.2.1. Some Brands Of Neurological Monitors
    • 4.1.3. Thoracic Surgery
    • 4.1.4. Biopsy
    • 4.1.5. Orthopedic Surgeries
    • 4.1.6. Laparoscopic Surgeries
    • 4.1.7. Emergency Care
    • 4.1.8. Other Surgeries
  • 4.2. Diagnostic Imaging
    • 4.2.1. Fluoroscopy
    • 4.2.2. Digital Subtraction Angiography
    • 4.2.3. Three-Dimensional (3d) C-Arm Computed Tomography

Chap 5. Market Segmentation By Device

  • 5.1. Operating Tables
    • 5.1.1. Mobile Operating Tables
    • 5.1.2. Stationary Operating Tables
  • 5.2. Operating Room Lights
    • 5.2.1. Dimmable Lights
    • 5.2.2. Led Lighting
    • 5.2.3. Halogens
  • 5.3. Surgical Booms
  • 5.4. Surgical Imaging Displays
    • 5.5. Intraoperative Diagnostic Devices
    • 5.5.1. 3D Ultrasound
    • 5.5.2. MRI (Magnetic Resonance Imaging)
      • 5.5.2.1. Top Brands And Manufacturers Of MRI
    • 5.5.3. Computer Tomography
    • 5.5.4. Computer Assisted Robotic Surgery
    • 5.5.5. C-Arm X-Ray
    • 5.5.6. Infra Red Imaging Systems
  • 5.6. Operating Room Communication Systems
    • 5.6.1. Audio Visual
    • 5.6.2. Operating Room Integration System
      • 5.6.2.1. WiFi
      • 5.6.2.2. RFID
      • 5.6.2.3. PACS

Chap 6. Geographical Analysis

  • 6.1. North America
    • 6.1.1. United States (U.S.)
      • 6.1.1.1. Prevalent Diseases In US
      • 6.1.1.2. Diabetes In The US
      • 6.1.1.3. The US Regulations (FDA)
    • 6.1.2. Canada
      • 6.1.2.1. Diseases Prevalent In Canada
        • 6.1.2.1.1. Cardiovascular Diseases (CVD)
        • 6.1.2.1.2. Cancer
        • 6.1.2.1.3. Diabetes
      • 6.1.2.2. Regulations In Canada
  • 6.2. Europe
    • 6.2.1. Regulations Regarding Medical Devices In Europe
    • 6.2.2. Prevalent Diseases In Europe
    • 6.2.3. United Kingdom (UK)
      • 6.2.3.1. Diseases Prevalent In UK
    • 6.2.4. France
    • 6.2.5. Germany
      • 6.2.5.1. Diseases Prevalent In Germany
    • 6.2.6. Spain
    • 6.2.7. Italy
  • 6.3. Asia Pacific
    • 6.3.1. India
      • 6.3.1.1. Prevalence Of CVD And Other Heart Diseases In India
      • 6.3.1.2. Regulations In India
      • 6.3.1.3. Opportunities In India
    • 6.3.2. China
      • 6.3.2.1. Diseases Prevalent In China
        • 6.3.2.1.1. CVD
        • 6.3.2.1.2. Regulations In China
    • 6.3.3. Japan
      • 6.3.3.1. Diseases Prevalent In Japan
      • 6.3.3.2. Regulations In Japan
    • 6.3.4. Korea
      • 6.3.4.1. Regulations In Korea
  • 6.4. Rest Of The World
    • 6.4.1. Latin America
      • 6.4.1.1. Brazil
        • 6.4.1.1.1. Prevalent Diseases In Brazil
        • 6.4.1.1.2. Mexico
        • 6.4.1.1.3. Regulations
        • 6.4.1.1.4. Prevalence Of Diseases In Mexico

Chap 7. Competitive Landscape

  • 7.1. Key Strategies
    • 7.1.1. Partnerships
    • 7.1.2. Acquisitions
    • 7.1.3. Product Launch

Chap 8. Company Profiling

  • 8.1. Barco Nv
    • 8.1.1. Overview
    • 8.1.2. Barco Nv Products Portfolio In Hybrid Or
    • 8.1.3. Strategic Moves
    • 8.1.4. SCOT Analysis
  • 8.2. Cook Medical
    • 8.2.1. Overview
    • 8.2.2. Cook Medical Products Portfolio In Hybrid OR
    • 8.2.3. SCOT Analysis
  • 8.3. Eschmann Equipment
    • 8.3.1. Overview
    • 8.3.2. Eschmann Product Portfolio In Hybrid OR
    • 8.3.3. SCOT Analysis
  • 8.4. GE Healthcare
    • 8.4.1. Overview
    • 8.4.2. GE Healthcare Product Portfolio In Hybrid Or
    • 8.4.3. Strategic Moves
    • 8.4.4. SCOT Analysis
  • 8.5. Johnson & Johnson
    • 8.5.1. Overview
    • 8.5.2. Johnson & Johnson Products Portfolio In Hybrid OR
    • 8.5.3. SCOT Analysis
  • 8.6. Karl Storz Gmbh & Co. KG
    • 8.6.1. Overview
    • 8.6.2. Karl Storz Product Portfolio In Hybrid OR
    • 8.6.3. Strategic Moves
    • 8.6.4. SCOT Analysis
  • 8.7. Maquet Getinge Group
    • 8.7.1. Overview
    • 8.7.2. Maquet Product Portfolio In Hybrid OR
    • 8.7.3. Strategic Moves
    • 8.7.4. SCOT Analysis
  • 8.8. Mediflex
    • 8.8.1. Overview
    • 8.8.2. Mediflex Product Portfolio In Hybrid OR
    • 8.8.3. SCOT Analysis
  • 8.9. Mizuho OSI
    • 8.9.1. Overview
    • 8.9.2. Mizuho OSI Product Portfolio In Hybrid OR
    • 8.9.3. Strategic Moves
    • 8.9.4. SCOT Analysis
  • 8.10. NDS Surgical Imaging, LLC
    • 8.10.1. Overview
    • 8.10.2. NDS Surgical Imaging Product Portfolio In Hybrid OR
    • 8.10.3. Strategic Moves
    • 8.10.4. SCOT Analysis
  • 8.11. Philips Healthcare
    • 8.11.1. Overview
    • 8.11.2. Phillips Healthcare Products Portfolio In Hybrid OR
    • 8.11.3. Strategic Moves
    • 8.11.4. SCOT Analysis
  • 8.12. Siemens Healthcare GMBH
    • 8.12.1. Overview
    • 8.12.2. Siemens Healthcare Products Portfolio In Hybrid OR
    • 8.12.3. Strategic Moves (2013-14)
    • 8.12.4. SCOT Analysis
  • 8.13. Sisco Ltd
    • 8.13.1. Overview
    • 8.13.2. Sisco Product Portfolio In Hybrid OR
    • 8.13.3. SCOT Analysis
  • 8.14. Sklar
    • 8.14.1. Overview
    • 8.14.2. Sklar Product Portfolio In Hybrid OR
    • 8.14.3. SCOT Analysis
  • 8.15. Skytron, LLC
    • 8.15.1. Overview
    • 8.15.2. Skytron Product Portfolio In Hybrid OR
    • 8.15.3. Strategic Moves
    • 8.15.4. SCOT Analysis
  • 8.16. Sontec Instruments
    • 8.16.1. Overview
    • 8.16.2. Sontec Instruments Product Portfolio In Hybrid OR
    • 8.16.3. Strategic Moves
    • 8.16.4. SCOT Analysis
  • 8.17. Steris Corporation
    • 8.17.1. Overview
    • 8.17.2. Steris Product Portfolio In Hybrid OR
    • 8.17.3. SCOT Analysis
  • 8.18. Stryker Corporation
    • 8.18.1. Overview
    • 8.18.2. Stryker Product Portfolio In Hybrid OR
    • 8.18.3. Strategic Moves
    • 8.18.4. SCOT Analysis
  • 8.19. Toshiba Medical Systems
    • 8.19.1. Overview
    • 8.19.2. Toshiba Medical System Products Portfolio In Hybrid OR
    • 8.19.3. Strategic Moves
    • 8.19.4. SCOT Analysis
  • 8.20. Trumpf Gmbh + Co. KG
    • 8.20.1. Overview
    • 8.20.2. Trumpf Product Portfolio In Hybrid OR
    • 8.20.3. Strategic Moves
    • 8.20.4. SCOT Analysis
Back to Top